Michael Kamm
Michael Kamm
Verified email at
Cited by
Cited by
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands, FH Anderson, CN Bernstein, WY Chey, BG Feagan, ...
New England Journal of Medicine 350 (9), 876-885, 2004
Anal-sphincter disruption during vaginal delivery
AH Sultan, MA Kamm, CN Hudson, JM Thomas, CI Bartram
New England journal of medicine 329 (26), 1905-1911, 1993
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis, P Frič, J Pokrotnieks, M Lukáš, B Fixa, M Kaščák, MA Kamm, ...
Gut 53 (11), 1617-1623, 2004
Prospective comparison of faecal incontinence grading systems
CJ Vaizey, E Carapeti, JA Cahill, MA Kamm
Gut 44 (1), 77-80, 1999
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
M Rutter, B Saunders, K Wilkinson, S Rumbles, G Schofield, M Kamm, ...
Gastroenterology 126 (2), 451-459, 2004
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ...
The Lancet 389 (10075), 1218-1228, 2017
Once daily high dose probiotic therapy (VSL# 3) for maintaining remission in recurrent or refractory pouchitis
T Mimura, F Rizzello, U Helwig, G Poggioli, S Schreiber, IC Talbot, ...
Gut 53 (1), 108-114, 2004
Mechanisms of action of probiotics: recent advances
SC Ng, AL Hart, MA Kamm, AJ Stagg, SC Knight
Inflammatory bowel diseases 15 (2), 300-310, 2009
Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair
AH Sultan, MA Kamm, CN Hudson, CI Bartram
Bmj 308 (6933), 887-891, 1994
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study
SC Ng, W Tang, JY Ching, M Wong, CM Chow, AJ Hui, TC Wong, ...
Gastroenterology 145 (1), 158-165. e2, 2013
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis
MD Rutter, BP Saunders, KH Wilkinson, S Rumbles, G Schofield, ...
Gastroenterology 130 (4), 1030-1038, 2006
Myths and misconceptions about chronic constipation
SA Müller-Lissner, MA Kamm, C Scarpignato, A Wald
Official journal of the American College of Gastroenterology| ACG 100 (1 …, 2005
Modulation of human dendritic cell phenotype and function by probiotic bacteria
AL Hart, K Lammers, P Brigidi, B Vitali, F Rizzello, P Gionchetti, ...
Gut 53 (11), 1602-1609, 2004
Characteristics of intestinal dendritic cells in inflammatory bowel diseases
AL Hart, HO Al-Hassi, RJ Rigby, SJ Bell, AV Emmanuel, SC Knight, ...
Gastroenterology 129 (1), 50-65, 2005
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn’s disease
S Schreiber, P Rutgeerts, RN Fedorak, M Khaliq–Kareemi, MA Kamm, ...
Gastroenterology 129 (3), 807-818, 2005
Development of the Crohn's disease digestive damage score, the Lemann score
B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ...
Inflammatory bowel diseases 17 (6), 1415-1422, 2011
AGA technical review on anorectal testing techniques
NE Diamant, MA Kamm, A Wald, WE Whitehead
Gastroenterology 116 (3), 735-760, 1999
Haemorrhoids: pathology, pathophysiology and aetiology
PB Loder, MA Kamm, RJ Nicholls, RKS Phillips
British journal of surgery 81 (7), 946-954, 1994
Crohn's disease management after intestinal resection: a randomised trial
P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ...
The Lancet 385 (9976), 1406-1417, 2015
Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma
AJ Malouf, CS Norton, AF Engel, RJ Nicholls, MA Kamm
The Lancet 355 (9200), 260-265, 2000
The system can't perform the operation now. Try again later.
Articles 1–20